miRecule and Rio Biofarma to develop RNA therapeutic delivery technologies
The collaboration seeks to develop delivery approaches that could make RNA therapeutics available to a broader tissue selection.
Drug Development
Resilience and Lilly to increase US medicines production with $750m investment
Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use
Synlogic and Caldera sign merger agreement
FDA regenerative medicine approvals show growing momentum
FDA grants fast track designation for HAYA Therapeutics’ HTX-001
Eisai and CORE Biomedicine agree on global licence for oncology pipeline
BioMarin and n-Lorem partner on early research for ReNU syndrome therapy
